209 — Birmingham, Alabama

209 is a clinical research site located in Birmingham, Alabama, United States.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

209 has participated in 2 clinical trials.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: UCB Pharma SA, UCB Pharma.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 209?

209 has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 209 conducted?

209 has 2 clinical trials on record. Their work covers Rheumatoid Arthritis.

Is 209 accredited by Crixeo Health?

209 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 209?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.